Psychological therapies may benefit CP/CPPS patients
March 1st 2006Baltimore--Psychological treatment, particularly cognitive behavioral therapy, can help ease chronic pain. That's why these therapies may be able to do the same for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) patients, argued Judith Turner, PhD, at the NIDDK-sponsored Chronic Pelvic Pain/Chronic Prostatitis Scientific Workshop here.
Neurophysiologic tests for CP/CPPS show promise
March 1st 2006Baltimore?Someday, you may be using neurophysiologic testing for follow-up and possibly even diagnosis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) before you turn to the four-glass or modified test. That's because, increasingly, CP/CPPS is being recognized not as a disorder of the prostate, but as a neurologic disorder?a chronic pain syndrome that may begin in the viscera, but becomes a nervous system disorder as pain is centralized.
Omega-6 fatty acids increase speed of prostate tumor growth
February 16th 2006Omega-6 fatty acids, such as those found in corn oil, appear to cause human prostate tumors in cell culture to grow twice as quickly as those to which omega-6 fats have not been added, according to a study conducted at the San Francisco VA Medical Center and published in Cancer Research (2006; 66:1427-33).
Race, poverty related to prostate cancer outcomes
February 16th 2006Only 25% of African-American men ages 60 to 69 years undergo PSA screening and 36% receive annual digital rectal exams, while just under 50% of African-Americans at high risk for the disease (those with a family history) undergo PSA tests and 38% receive DREs, according to a study published in Cancer (2006; 106:796-803).
Saw palmetto takes a hit in long-term BPH study
February 16th 2006The popular herbal therapy saw palmetto appears to be no more effective than placebo for relieving symptoms of BPH, according to a year-long, double-blind study published last week in the New England Journal of Medicine (2006; 354:557-66).
IVU founder receives international medicine award
February 2nd 2006The American Medical Association has awarded the Dr. Nathan Davis International Award in Medicine to Catherine deVries, MD, founder and president of International Volunteers in Urology (IVU), a Salt Lake City-based nonprofit organization dedicated to providing medical education and treatment in developing countries.
Study finds no link between fish oil, lower cancer incidence
February 2nd 2006Contrary to popular thinking, consuming food or dietary supplements such as fish oil that contain omega-3 fatty acids provides no protection against developing cancer, according to a study examining 4 decades of medical literature (JAMA 2006; 295:403-15).
Nonobstructive azoospermia is tied to genetic defect
February 1st 2006Montreal--Idiopathic, primary nonobstructive azoospermia (NOA) is linked to a genetic defect known as a dysfunctional DNA mismatch repair pathway that also places these men at increased risk for cancer and other medical illnesses. Given that the problem is genetic in origin, the consequences of this defect may be of significance for both patients and their offspring, researchers say. Both concerns require close monitoring by physicians.
Vasectomy reversal: Data point to choice of technique
February 1st 2006Montreal--As the controversy over whether to perform vasovasostomy or vasoepididymostomy for vasectomy reversal rages, two small studies have provided some new insight into when to choose one surgical technique over the other. One study demonstrates that expert surgeons can provide better results with vasoepididymostomy among patients with vasospermia, defined as no sperm in the vasal fluid, regardless of the condition of the vasal fluid. The second study suggests that the presence of sperm parts in the vasal fluid signals that vasovasostomy might be the better option.
Inhibin B: A better infertility marker than FSH or LH?
February 1st 2006Montreal--The level of inhibin B may be a better marker of male infertility than both the typically used follicle stimulating hormone (FSH) and luteinizing hormone (LH), according to new research. These findings have yet to be confirmed in a large, prospective trial, however.
Ultrasound may be useful in assessment of Peyronie's
February 1st 2006New York--Routine ultrasound assessment of the flaccid penis in patients with Peyronie's disease gives otherwise unobtainable clinical evidence that is useful in treatment, according to results of a large study from the University of California, San Francisco.
Rehab program improves erectile function after RP
February 1st 2006New York--A multifaceted rehabilitation program designed to improve erectile performance and penile length in men undergoing radical prostatectomy was successful in nearly three-fourths of cases, according to researchers from the M.D. Anderson Cancer Center in Houston.
Fast-acting PDE-5 inhibitor shows positive results
February 1st 2006New York--Avanafil, an investigational, fast-acting phosphodiesterase type-5 inhibitor, has been successful in its first large-scale trial, Joel M. Kaufman, MD, reported at the Sexual Medical Society of North America annual meeting here.
Gender identity and assignment issues spark debate
February 1st 2006Washington--For children with ambiguous genitalia at birth, surgical techniques have improved vastly, but deciding when and whether to do surgery hasn't gotten easier. That was apparent from the lively and sometimes contentious panel and audience discussion here at the American Academy of Pediatrics Section on Urology annual meeting.
Data shed light on bladder augmentation risks
February 1st 2006Washington--Long-term experience with bladder augmentation in children is now giving pediatric urologists and parents a true picture of the risks and benefits of different bowel segments. No single segment was the obvious winner in two experimental studies presented here at the American Academy of Pediatrics Section on Urology annual meeting, but the maintenance and surveillance required has become clearer. Other than technical considerations, metabolic, rather than urodynamic considerations, may prove more important in deciding which segment to use.